February 2021
2021
24/02/2021
PromarkerD at EDEC 2021
10/02/2021
PromarkerD: Predicting Diabetic Kidney Disease Before Symptoms Arrive – Medical Forum Magazine
09/02/2021
Proteomics International (ASX:PIQ) pursues FDA approval for PromarkerD – The Market Herald
09/02/2021
Proteomics seeks FDA approval for blood test kit – The West Australian
08/02/2021
Proteomics International seeks FDA approval for PromarkerD
Newsroom
Private: In the Media
Presentations
Newsletters
Publications
Events
News Archive
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Comments
This field is for validation purposes and should be left unchanged.
Company
About Us
Board
Clinical Advisory Board
Mission Statement
Senior Staff
Quality
Customer Testimonials
Careers
Glossary
PromarkerD
Diagnostics
Biomarker Discovery
The Promarker™ Pipeline
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Proteome Quantitation (iTRAQ, TMT, Label-Free)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Terms and Conditions
FAQs
Newsroom
Media Releases
Media Coverage
Videos
Science & Technology
Presentations
Newsletters
Publications
Events
Investors
Share Price and Analyst Coverage
ASX Announcements
Corporate Media
Corporate Presentations
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents
